Iris Hardewig

Director of Scientific Affairs, Sanity Group

Iris is Director of Scientific Affairs at the Sanity Group. Founded in 2018, Sanity Group has become one of Europe’s leading medical cannabis firms, raising €20.1 million at the beginning of 2020. Iris has been instrumental to that growth. After receiving her PhD in animal physiology at the Heinrich-Heine University, Duesseldorf, she spent several years in academic science. For more than 10 years, Iris has supported the natural health industry in product development and market access as Head of Consulting and Strategic Innovation at analyze & realize in Berlin.